ATC/DDD-METHODOLOGY FOR USING NEUROLEPTICS IN HOSPITAL AND MENTAL HEALTH FACILITY IN KHABAROVSK

Abstract

The paper analyses the provision of patients suffering from schizophrenia in Khabarovsk Krai in 2009-2011 with medications and highlights the increasing consumption of neuroleptics: by 77.4 % in money terms in hospital and by 33.3% in mental health facility. The patients contributed 59.3% of the total financing. The authors showed up the double increase in the consumption of neuroleptics from 17.26 to 35.52 DDD/100 bed/days in hospital (due to increasing volume of chlorpromazine usage to 17.25, clozapine to 7.7 and thioridazine to 3.5 DDD/100 bed-days). The increasing consumption of neuroleptics in the mental health facilities during the period under study has increased from 30.7 to 53.2 DDD/100 bed-days; haloperidol took the leading position (usage 20.5 DDD/100 bed-days), then followed chlorpromazine (13.8 DDD/100 bed-days), fluphenazine (5.3 DDD/100 bed-days), and clozapine (5.1 DDD/100 bed-days).